Advance research of insulin resistance in polycystic ovary syndrome

Journal of Jilin University Medicine Edition

Volumn 36, Issue 2, 2010, Pages 424-428

  Xie, Tie Nan ^a   Yue, Ying ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

CLINICAL RESEARCH; FEMALE; GLUCOSE INTOLERANCE; HIRSUTISM; HUMAN; INSULIN RESISTANCE; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 77950921741     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. The Rotterdam ESHRE/ASRM - Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polycystic ovary syndrome (PCOS) [J]. Hum Reprod, 2004, 19 (1): 41-47.
2. Azziz R, Carmina E, DewaillyD, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline [J]. J Clin Endocrinol Metab, 2006, 91 (11): 4237-4245.
3. Trader BC, Pall M, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in a group of women presenting with oligomenorrhea or Hirsutism: NIH 1990 vs. Rotterdam 2003 Criteria [C]. The 88th Annual Meeting of The Endocrine Society, Boston, MA, 2006: 2-601.
4. Ibanez L, Dimartino-Nardi J, Potau N, et al. Premature adren-arche-normal variant or forerunner of adult disease? [J]. Endocr Rev, 2000, 21 (6): 671-696.
5. Unluhizarci K, Ozocak M, TanriverdiF, et al. Investigation of hypothalamo- pituitary -gonadal axis and glucose intolerance among the first-degree female relatives of women with polycystic ovary syndrome [J]. Fertil Steril, 2007, 87 (6): 1377-1382.
6. Leibel NI, Baumann EE, Kochergin sky M, et al. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome [J]. J Clin Endocrinol Metab, 2006, 91 (4): 1275-1283.
7. Gambineri A, Pelusi C, Vicennati V, et al. Obesity and the polycystic ovary syndrome [J]. Int J Obes Relat Metab Disord, 2002, 26 (7): 883-896.
8. Linne Y. Effects of obesity on women's reproduction and complications during pregnancy [J]. Obes Rev, 2004, 5 (3): 137-143.
9. Pandolfi C, Zugaro A, Lattanzio F, et al. Low birth weight and later development of insulin resistance and biochemical/features of polycystic ovary syndrome [J]. Metabolism, 2008, 57 (7): 999-1004.
10. Ibáñez Díaz R, López-Bermejo AL, et al. Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism [J]. Rev Endocr Metab Disord, 2009, 10 (1): 63-76.
11. Waterworth DM, Bennett ST, Gharani N, et al. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome [J]. Lancet, 1997, 349 (9057): 986-990.
12. Powell BL, Haddad L, Bennett A, et al. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic owary syndrome or related traits [J]. J Clin Endocrinol Metab, 2005, 90 (5): 2988-2993.
13. Siegel S, Futterweit W, Davies TF, et al. AC/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor geneis associated with polycystic ovary syndrome [J]. Fertil Steril, 2002, 78 (6): 1240-1243.
14. Seow KM, Juan CC, Wu LY, et al Serum and adipoeyte resistin in polycystic ovary syndrome with insulin resistane [J]. Hum Reprod, 2004, 19 (1): 48-53.
15. Elmkaedem SA, Lautier C, Macari F, et al. Role of allelic vailants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome [J]. Diabetes, 2001, 50 (9): 2164-2168.
16. Rice S, Christoforidis N, Gadd C, et al. Impaired insulin-dependent glucose metabolism in granulisa-lutein cells from anovulatory woman with polycystic ovaries [J]. Hum Reprod, 2005, 20 (2): 373-381.
17. Moran C, Huerta R, Conway-Myers BA, et al. Altered autopho-sphorylation of the insulin receptor in the ovary of a woman with polycystic ovary syndrome [J]. Fertil Steril, 2001, 75 (3): 625-628.
18. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma [J]. Lancet, 2003, 24 (361): 1810-1812.
19. Berstein LM, Kvatchevskaya JO, Poroshina TE, et al. Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer [J]. J Cancer Res Clin Oncol, 2004, 130 (4): 687-693.
20. Maliqueo M, Bacallao K, Quezada S, et al. Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome [J]. Fertil Steril, 2007, 87 (2): 321-328.
21. Ahmad A, Jay F, Husam G, et al. Glucose ingestion induces an increase In intranuclear nuclear factor, a fall in cellular inhibitor, and an increase in tumor necrosis factor a messenger RNA [J]. Metab, 2007, 17 (4): 1177-1185.
22. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue [J]. J Clin Invest, 2003, 112 (12): 1796-1808.
23. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease [J]. Endocr Rev, 2003, 24 (3): 313-340.
24. Claughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant [J]. Ann Int Med, 2003, 139 (18): 802-809.
25. Cetinkalp S, Karadeniz M, Erdogan M, et al. Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey [J]. J Assist Reprod Genet, 2009, 26 (1): 1-6.